ERBB2 and neoplasm: It has been previously reported that pathological characteristics differ between HER2 IHC 3+ and HER2 IHC 2+/HER2 amplified tumours: IHC 3+ tend to be of higher histological grade, larger tumour size, and are often ER-negative and PR-negative [34].